Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Foot (Edinb) ; 46: 101748, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33465526

RESUMEN

INTRODUCTION: At present, health facilities are forced to switch to outpatient care. While it lends itself well to this organizational arrangement, first ray surgery is broadly considered as painful by patients, who are often reluctant to this treatment. The evolution of post-operative pain in patients who underwent operations for first ray surgery from D0 to D15 were studied. Secondly, the duration of the oral analgesic treatment, the patient's satisfaction level, and searched for complications were assessed. METHODS: This is an observational, single-center and single-operator study. Between July and December 2019, forty patients who underwent first ray surgery (hallux valgus or rigidus) and eligible for outpatient treatment were included. The surgical technique of the hallux valgus treatment consisted of open surgery via double metatarsal and phalangeal osteotomy. The hallux rigidus surgery consisted of arthrodesis using an open dorsal plate. Home monitoring was carried out by a healthcare provider (e-HORUS). The protocol provided for pain management by means of a diffuser of Nefopam IV for a maximum of 5 days, combined with alleviating oral analgesics 1 and 2 and NSAIDs. The pain was evaluated on D0, D1, D3, D5, D8 and D15, using a numerical scale (NS) from 0 to 10. The degree of patient satisfaction was recorded at 1 month. RESULTS: 35 patients were followed. 5 patients were excluded due to incomplete data. The series included 26 women and 9 men, with an average age of 59.9 years. There were 30 hallux valgus and 5 hallux rigidus. The pain analyzed by the NS was 5.37 on D0, 3.34 on D1, 1.83 on D3, 1.43 on D5, 1.06 on D8 and 2.2 on D15. The average duration of Nefopam infusions was 3.89 days, and the average duration of oral analgesics was 17.7 days. The tolerance of the treatment was satisfactory in 79% of the cases. 69% of patients were very satisfied with the management of their pain. There were no scar complications or infections. No re-hospitalization was necessary. 3 algoneurodystrophies were identified. The existence of fibromyalgia or Parkinsonian syndrome was correlated with higher pain. DISCUSSION-CONCLUSION: Pain management after outpatient first ray surgery using the injectable Nefopam protocol was satisfactory in the majority of cases, with a high degree of patient satisfaction. This protocol is routinely offered to our patients who must undergo first ray surgery.


Asunto(s)
Hallux Rigidus , Hallux Valgus , Articulación Metatarsofalángica , Procedimientos Quirúrgicos Ambulatorios , Femenino , Estudios de Seguimiento , Hallux Valgus/cirugía , Humanos , Masculino , Articulación Metatarsofalángica/cirugía , Persona de Mediana Edad , Dolor Postoperatorio/diagnóstico , Dolor Postoperatorio/prevención & control , Resultado del Tratamiento
2.
Neurochem Int ; 38(7): 601-8, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11290385

RESUMEN

The transcription factor cAMP-response element binding protein 2 (CREB2), a member of the family of basic region leucine zipper proteins, has been suggested to function in the brain as a repressor of long-term memory. Using recombinant proteins we show that CREB2 binds in vitro to the palindromic cAMP response element derived from the secretogranin II gene. Recent studies of the chromogranin B, secretogranin II and enkephalin genes showed that CREB2 functioned as a repressor of cAMP-induced transcription. We analyzed the ability of CREB2 to repress transcription using model promoters. A molecular dissection of the CREB2 molecule revealed that CREB2 lacks a transferable repressor domain suggesting that CREB2 may function solely as a "passive" transcriptional repressor. In contrast, "active" repressor domains derived from the thyroid hormone receptor alpha or the NK10 zinc finger protein containing a "Krüppel associated box" could be transfered to a heterologous DNA-binding domain and functioned as fusion proteins in repressing transcription of a reporter gene. In addition, a strong activation domain located at the N-terminus was identified in the CREB2 protein suggesting that CREB2 may act as an activator of transcription by binding to different genetic regulatory elements.


Asunto(s)
Factores de Transcripción/química , Factor de Transcripción Activador 4 , Glutatión Transferasa/química , Humanos , Conformación Proteica , Proteínas Recombinantes de Fusión/química , Células Tumorales Cultivadas
3.
Scand J Surg ; 102(2): 87-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23820682

RESUMEN

BACKGROUND AND AIMS: The insertion of prophylactic ureteral stents in traditional colorectal surgery has been debated for a long time. The aim of this study is to investigate the results of ureteric stent insertion in elective laparoscopic colorectal surgery in terms of complications and costs. MATERIAL AND METHODS: From June 2009 to June 2011 one or two prophylactic ureteral stents were placed in all patients undergoing elective laparoscopic resection of their colon or rectum. RESULTS: A total of 89 patients took part in this study, 61% had a benign disease and 39% malignant. The mean time for ureteral stent insertion was 16 min if one-sided and 21 min if bilateral. Incidental findings were found in the bladder in four (4.5%) patients. In all, 13 (26%) male patients had a benign prostatic adenoma, and 3 (6%) male patients had a significant stenosis of the urethral meatus and required bouginage. Complications due to ureteral stent insertion were transient hematuria in 11 (12.3%) cases, postoperative urinary tract infections in 2 (2.2%) cases, and hydronephrosis in 2 (2.2%) cases. One patient suffered an accidental damage of the right ureter despite the presence of a stent; this was recognized intraoperatively. The total cost for a one-sided ureteral stent insertion is calculated at around €360, and for a bilateral ureteral stent insertion, it is around €410. CONCLUSIONS: The prophylactic use of a ureteral stent in laparoscopic colorectal surgery leads to minor complications and may be cost-effective.


Asunto(s)
Colectomía/métodos , Procedimientos Quirúrgicos Electivos/métodos , Complicaciones Intraoperatorias/prevención & control , Laparoscopía/métodos , Recto/cirugía , Stents , Uréter/lesiones , Adulto , Anciano , Anciano de 80 o más Años , Colectomía/efectos adversos , Colectomía/economía , Procedimientos Quirúrgicos Electivos/efectos adversos , Procedimientos Quirúrgicos Electivos/economía , Femenino , Alemania , Humanos , Complicaciones Intraoperatorias/economía , Laparoscopía/efectos adversos , Laparoscopía/economía , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/economía , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Stents/economía , Resultado del Tratamiento
4.
Chirurg ; 83(3): 247-53, 2012 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-21901465

RESUMEN

Laparoscopic pancreatic surgery is not common practice in Germany and is only carried out in approximately 20 clinics but with an increasing trend. The reasons for this are manifold, such as the current selection of patients and both skills in laparoscopic and pancreatic surgery are necessary to perform this operation safely. In 2008 a registry called "Laparoscopic pancreatic surgery" was implemented to collect enough data in Germany to find out whether the resection is safe, feasible and beneficial for the patient.For further development of new laparoscopic techniques new data is needed. A group of experts performing laparoscopic pancreatic surgery in Germany supplied their data for the German registry for laparoscopic pancreatic resection and a consensus conference about the indications became necessary. This consensus conference discussed in particular the indications for laparoscopic pancreatic resection. A consensus was found by all members of the conference utilizing currently available evidence-based data.It was suggested that all data of laparoscopic pancreatic surgery should be evaluated in the German Registry. A consensus was made which diseases were either suitable for laparoscopic resection or not suitable or suitable in selected cases.


Asunto(s)
Laparoscopía/métodos , Pancreatectomía/métodos , Enfermedades Pancreáticas/cirugía , Neoplasias Pancreáticas/cirugía , Sistema de Registros , Medicina Basada en la Evidencia , Estudios de Factibilidad , Alemania , Humanos , Enfermedades Pancreáticas/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Complicaciones Posoperatorias/etiología , Pronóstico , Sociedades Médicas
5.
Unfallchirurg ; 92(1): 21-5, 1989 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-2916132

RESUMEN

Stress fracture of the femoral neck is rare, and the conditions in which it occurs are complex. An unusually high, rhythmically acting force resulting from body weight and muscle tension leads to decompensation of the dynamic equilibrium otherwise prevalent in bone metabolism in conditions of adaptation. Even small differences in leg length predispose to fracture of the longer leg, owing to the increased muscular activity. Bone scanning is helpful in diagnosis when no signs of fracture are revealed by conventional radiography. Internal fixation that will allow weight-bearing should be attempted. In this case report an instance of this type of fracture in a marathon runner is presented.


Asunto(s)
Traumatismos en Atletas , Trastornos de Traumas Acumulados/etiología , Fracturas del Cuello Femoral/etiología , Carrera , Traumatismos en Atletas/diagnóstico por imagen , Traumatismos en Atletas/fisiopatología , Fenómenos Biomecánicos , Trastornos de Traumas Acumulados/fisiopatología , Fracturas del Cuello Femoral/diagnóstico por imagen , Fracturas del Cuello Femoral/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Radiografía
6.
Biochem J ; 360(Pt 3): 599-607, 2001 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-11736649

RESUMEN

The activator protein 1 (AP-1) transcription factor is composed of heterodimers of the Fos/activating transcription factor (ATF) and Jun subfamilies of basic-region leucine-zipper (B-ZIP) proteins. In order to determine the identities of individual B-ZIP proteins in various AP-1 complexes we tested the effect of dominant-negative mutants to the B-ZIP proteins c-Fos, ATF2, ATF4 and CCAAT-enhancer-binding protein (C/EBP) on the activities of the collagenase and c-Jun promoters. These dominant-negative mutants inhibit DNA binding of wild-type B-ZIP proteins in a leucine-zipper-dependent fashion. Transcription of a collagenase promoter/reporter gene was induced in HepG2 hepatoma cells by expression of c-Fos and c-Jun, administration of PMA ("TPA") or by expression of a truncated form of MEK (mitogen-activated/extracellular-signal-regulated kinase kinase) kinase-1, MEKK1Delta. In all cases, the dominant-negative mutants A-Fos and A-ATF2 decreased collagenase promoter activity. However, A-ATF4 and A-C/EBP had no effect. A-Fos and A-ATF2 also reduced MEKK1Delta-induced stimulation of the c-Jun promoter. In contrast, constitutive c-Jun promoter activity was blocked solely by A-ATF2, strongly suggesting that ATF2 and/or an ATF2-dimerizing protein are of major importance for c-Jun transcription in unstimulated cells. These results demonstrate that AP-1 transcription factors of different compositions control c-jun gene transcription in resting or stimulated cells.


Asunto(s)
Colagenasas/genética , Regulación Neoplásica de la Expresión Génica , Quinasa 1 de Quinasa de Quinasa MAP , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas c-jun/genética , Factor de Transcripción AP-1/metabolismo , Secuencia de Aminoácidos , Carcinoma Hepatocelular , Células Cultivadas , Genes Reporteros , Genes jun , Humanos , Leucina Zippers , Neoplasias Hepáticas , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Factor de Transcripción AP-1/química , Factores de Transcripción/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA